Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | If elected by our stockholders, Dr. Lanchoney will join the Board as a director immediately upon the conclusion of the Annual Meeting. She will receive the long-term equity-based incentive compensation payable to our directors upon their initial appointment to the Board. |
| 2022-02-28 | Current Directors Diana Lanchoney, M.D. (8) 104,125 0.1% |
| 2022-03-28 | Current Directors Diana Lanchoney, M.D. 115,695 shares |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25